The title compound,pteridin-10(2H)-yl)ethylidene]-4-nitrobenzohydrazide (1), was obtained by the reaction of formylmethylflavin and p-nitrobenzohydrazide. The product 1 inhibited the DNA binding of nuclear factor-κB, and was characterized by 1 H-NMR, 13 C-NMR, electrospray ionization mass spectrometry, elemental analysis, IR and UV.Nuclear factor-κB (NF-κB) is a transcription factor which regulates the expression of proteins that play key roles in immunity and inflammation [1][2][3][4]. Consequently, NF-κB is considered a good target for the treatment of many diseases such as cancers and chronic inflammatory diseases [5][6][7][8][9][10]. To find NF-κB inhibitors, we screened our chemical library of small molecule compounds, and found triazine and flavin. Triazine derivatives directly inhibit the DNA binding of NF-κB [11,12]. Moreover, we synthesized several flavin derivatives [13,14] and tested their inhibitory effects on the DNA binding of NF-κB by performing electrophoretic mobility shift assays (EMSA) as previously reported [11,12]. The title compound,